Polybromo‐1 (
PBRM
1) is an important tumor suppressor in kidney cancer. It contains six tandem bromodomains (
BD
s), which are specialized structures that recognize acetyl‐lysine residues. While
BD
2 has been found to bind acetylated histone H3 lysine 14 (H3K14ac), it is not known whether other
BD
s collaborate with
BD
2 to generate strong binding to H3K14ac, and the importance of H3K14ac recognition for the molecular and tumor suppressor function of
PBRM
1 is also unknown. We discovered that full‐length
PBRM
1, but not its individual
BD
s, strongly binds H3K14ac.
BD
s 2, 4, and 5 were found to collaborate to facilitate strong binding to H3K14ac. Quantitative measurement of the interactions between purified
BD
proteins and H3K14ac or nonacetylated peptides confirmed the tight and specific association of the former. Interestingly, while the structural integrity of
BD
4 was found to be required for H3K14ac recognition, the conserved acetyl‐lysine binding site of
BD
4 was not. Furthermore, simultaneous point mutations in
BD
s 2, 4, and 5 prevented recognition of H3K14ac, altered promoter binding and gene expression, and caused
PBRM
1 to relocalize to the cytoplasm. In contrast, tumor‐derived point mutations in
BD
2 alone lowered
PBRM
1's affinity to H3K14ac and also disrupted promoter binding and gene expression without altering cellular localization. Finally, overexpression of
PBRM
1 variants containing point mutations in
BD
s 2, 4, and 5 or
BD
2 alone failed to suppress tumor growth in a xenograft model. Taken together, our study demonstrates that
BD
s 2, 4, and 5 of
PBRM
1 collaborate to generate high affinity to H3K14ac and tether
PBRM
1 to chromatin. Mutations in
BD
2 alone weaken these interactions, and this is sufficient to abolish its molecular and tumor suppressor functions.